DK0475994T3 - Macrolider til behandling af reversible obstruktive luftvejssygdomme - Google Patents

Macrolider til behandling af reversible obstruktive luftvejssygdomme

Info

Publication number
DK0475994T3
DK0475994T3 DK90908603.5T DK90908603T DK0475994T3 DK 0475994 T3 DK0475994 T3 DK 0475994T3 DK 90908603 T DK90908603 T DK 90908603T DK 0475994 T3 DK0475994 T3 DK 0475994T3
Authority
DK
Denmark
Prior art keywords
treatment
macrolides
reversible obstructive
obstructive airway
airway diseases
Prior art date
Application number
DK90908603.5T
Other languages
Danish (da)
English (en)
Inventor
Alan Anthony Norris
Dale Michael Jackson
Sohei Makino
Takeshi Fukuda
Ikuo Akutsu
Original Assignee
Fisons Plc
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898912935A external-priority patent/GB8912935D0/en
Priority claimed from JP2096045A external-priority patent/JPH03291225A/ja
Application filed by Fisons Plc, Fujisawa Pharmaceutical Co filed Critical Fisons Plc
Application granted granted Critical
Publication of DK0475994T3 publication Critical patent/DK0475994T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK90908603.5T 1989-06-06 1990-06-06 Macrolider til behandling af reversible obstruktive luftvejssygdomme DK0475994T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912935A GB8912935D0 (en) 1989-06-06 1989-06-06 Method of treatment
JP2096045A JPH03291225A (ja) 1990-04-09 1990-04-09 抗喘息薬

Publications (1)

Publication Number Publication Date
DK0475994T3 true DK0475994T3 (da) 1995-01-09

Family

ID=26295442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908603.5T DK0475994T3 (da) 1989-06-06 1990-06-06 Macrolider til behandling af reversible obstruktive luftvejssygdomme

Country Status (13)

Country Link
EP (1) EP0475994B1 (de)
JP (1) JP2508918B2 (de)
KR (1) KR0147852B1 (de)
AT (1) ATE111353T1 (de)
AU (1) AU639460B2 (de)
CA (1) CA2054203C (de)
DE (1) DE69012560T2 (de)
DK (1) DK0475994T3 (de)
ES (1) ES2061043T3 (de)
GR (1) GR1000738B (de)
IE (1) IE64214B1 (de)
PT (1) PT94292B (de)
WO (1) WO1990014826A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
ES2154262T3 (es) * 1991-04-26 2001-04-01 Fujisawa Pharmaceutical Co Uso de compuestos macrolidos para enfermedades oculares.
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
EP1699456A1 (de) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Verwendung von makroliden zur behandlung oder prävention von luftflussobstruktion
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
KR102293890B1 (ko) * 2018-12-11 2021-08-27 주식회사 몰젠바이오 신규 화합물 및 이를 포함하는 발모 촉진용 조성물
CN113939519B (zh) * 2018-12-11 2025-02-14 莫尔根生物有限公司 促进毛发生长的新化合物及包含它们的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
GR900100428A (en) 1991-11-15
DE69012560D1 (de) 1994-10-20
KR920700638A (ko) 1992-08-10
GR1000738B (el) 1992-12-30
IE902002L (en) 1990-12-06
AU639460B2 (en) 1993-07-29
EP0475994A1 (de) 1992-03-25
JPH05503283A (ja) 1993-06-03
WO1990014826A1 (en) 1990-12-13
JP2508918B2 (ja) 1996-06-19
PT94292B (pt) 1997-01-31
KR0147852B1 (ko) 1998-08-17
ES2061043T3 (es) 1994-12-01
PT94292A (pt) 1991-02-08
ATE111353T1 (de) 1994-09-15
IE64214B1 (en) 1995-07-26
CA2054203A1 (en) 1990-12-07
CA2054203C (en) 2001-08-21
EP0475994B1 (de) 1994-09-14
DE69012560T2 (de) 1995-03-09
AU5721490A (en) 1991-01-07

Similar Documents

Publication Publication Date Title
ATE111353T1 (de) Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.
DE69827236D1 (en) Matrix-metalloproteinase-hemmer
DE60102815D1 (de) 7-substituierte kondensierte ring-tetrazyclin- verbindungen
MX9701538A (es) Sales de un derivado del indol contra la migraña.
TW243449B (de)
ATE199083T1 (de) Terphenylverbindungen und sie enthaltende arzneimittel
IL110060A (en) 5-Amino-8- methyl-7-pyrrolidinylquinoline 3-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them
DK196688D0 (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
AU655869B2 (en) An amphoteric tricyclic compound
IE780926L (en) Chromene derivatives
ATE198746T1 (de) Pyrimidinderivate und pharmazeutische zusammensetzungen
AU6012390A (en) Anti-psychotic piperidylbenzimidazole compounds
JPS55122767A (en) Imidazole derivative*its manufacture and medical composition containing it
AUPO990097A0 (en) Medicinal uses of phenylalkanols and derivatives (gingerol analogues)
HUT62890A (en) Process for producing benzothiazole derivatives and pharmaceutical compositions comprising such compounds
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
MX9601163A (es) Nuevos compuestos derivados de cromeno.
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
SE9402596L (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
AU6014990A (en) New n-(23-vinblastinoyl) and n-(5'-noranhydro-23- vinblastinoyl) derivatives of 1-aminomethylphosphonic acid, process for preparing these and pharmaceutical compositions containing them
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
DE60121817D1 (de) Blockade der natriumkanäle durch phenolderivate
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application